Convalescent plasma therapy in a pregnant COVID-19 patient with a dramatic clinical and imaging response: A case report
Open Access
- 28 July 2020
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Radiology
- Vol. 12 (7), 137-141
- https://doi.org/10.4329/wjr.v12.i7.137
Abstract
BACKGROUND Coronavirus disease 2019 (COVID-19) is a novel very contagious infection which was designated a pandemic in all countries of the world in April 2020. Its presentation varies from mild to severe infection, but the majority of infected patients have mild manifestations. Many therapeutic choices have been suggested to treat the infection, but none are fully effective. CASE SUMMARY Herein we present a 26-year-old woman with a twin pregnancy at 36 wk and one day gestation with confirmed COVID-19 who responded dramatically to convalescent plasma therapy (CPT) and Favipiravir. CONCLUSION Although this case report shows the efficacy of CPT in addition to usual medications used for COVID-19, there are many questions that need to be answered regarding dosage, para-clinical efficacy, side effects and combination therapy.This publication has 19 references indexed in Scilit:
- Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to knowAmerican Journal of Obstetrics and Gynecology, 2020
- Convalescent plasma as a potential therapy for COVID-19The Lancet Infectious Diseases, 2020
- Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive studyThe Lancet Infectious Diseases, 2020
- Management of pregnant women infected with COVID-19The Lancet Infectious Diseases, 2020
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control StudyEngineering, 2020
- Infants Born to Mothers With a New Coronavirus (COVID-19)Frontiers in Pediatrics, 2020
- Withdrawn: Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancyJournal of Infection, 2020
- Remdesivir as a possible therapeutic option for the COVID-19Travel Medicine and Infectious Disease, 2020
- Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical recordsThe Lancet, 2020
- Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy menAmerican Journal of Physiology-Endocrinology and Metabolism, 2008